Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy

Giulia Petroni, Guido Kroemer, Lorenzo Galluzzi

    Résultats de recherche: Contribution à un journalBrève enquêteRevue par des pairs

    Résumé

    Autologous T cells engineered to express a chimeric antigen receptor (CAR) remain poorly effective against solid tumors, partly because solid neoplasms can establish an immunosuppressive microenvironment. Recent findings by Srivastava et al. suggest that immunogenic chemotherapeutics such as oxaliplatin can be harnessed to maximize the capacity of CAR T cells to infiltrate and control solid tumors.

    langue originaleAnglais
    Pages (de - à)179-181
    Nombre de pages3
    journalTrends in Cancer
    Volume7
    Numéro de publication3
    Les DOIs
    étatPublié - 1 mars 2021

    Contient cette citation